Biotherapeutics are key in the treatment and prevention of a host of illnesses and diseases. The manufacture of these life-saving medicines is a complex process that requires substantial investments of time and resources.
Microarray testing can be leveraged to assist in the research, Quality Control, and in-process testing stages of biotherapeutic development and manufacture. Currently, with support from the National Institute of Allergy and Infectious Diseases, we are developing a new protein analysis platform (VaxArray™ Influenza) that will revolutionize protein quantification for vaccine and biotherapeutic developers. Continue to check here and our Research & Development page for updates on VaxArray Influenza and other products. Contact us for more information about host cell protein and other QC assays in development and checkout our miPLEX product line for more information about developing your own array.